Find comprehensive information on Cocaine Use, including clinical documentation, medical coding, and healthcare resources for diagnosis. Learn about Cocaine Abuse, Cocaine Dependence, and Cocaine Addiction, along with related terms for accurate medical records and billing. This resource supports healthcare professionals in proper diagnosis and coding for Cocaine-related disorders.
Cocaine use involves the recreational use of cocaine, leading to potential addiction and health problems.
Euphoria, increased energy, talkativeness, paranoia, dilated pupils, rapid heart rate. Severe cases: seizures, heart attack, stroke.
Emergency rooms, addiction treatment centers, primary care clinics, behavioral health facilities.
Complete code families applicable to F14.90
| Description | When to use |
|---|---|
| Stimulant use disorder involving cocaine. | Code for recurrent cocaine use causing impairment or distress. Consider severity specifiers. |
| Stimulant use disorder, excluding cocaine. | Code for recurrent amphetamine, methamphetamine, or other stimulant use (not cocaine) causing impairment. |
| Other (or unknown) substance use disorder. | Code for substance use disorders not fitting other categories, or when the specific substance is unknown. |
Coding cocaine use without specifying current, in remission, or history can lead to inaccurate severity and reimbursement.
Overlooking and failing to code related conditions like cocaine-induced psychosis or cardiac arrhythmia impacts clinical documentation improvement (CDI) and quality metrics.
Discrepancies between physician notes, lab results, and patient statements regarding cocaine use create compliance risks and coding challenges for abuse, dependence, or addiction.
Has patient acknowledged cocaine use ICD-10 F14.10 DSM-5 304.20?
Document route, frequency, and quantity of cocaine use for accurate coding.
Screen for cocaine-related complications cardiovascular, neurological, psychiatric.
Assess for withdrawal symptoms and provide appropriate management protocols.
Consider referral to addiction specialist for treatment therapy, support groups.
Patient presents with signs and symptoms suggestive of cocaine use disorder, fulfilling DSM-5 diagnostic criteria. Clinical indicators observed include increased heart rate, elevated blood pressure, dilated pupils, and psychomotor agitation. The patient reports a pattern of cocaine use leading to significant impairment in social and occupational functioning, including neglecting responsibilities at work and strained relationships with family. He acknowledges cravings for cocaine, difficulty controlling cocaine intake, and continued use despite adverse consequences. The patient denies any current withdrawal symptoms but describes past experiences with cocaine withdrawal, including fatigue, increased appetite, and vivid dreams. Differential diagnoses considered include amphetamine use disorder, anxiety disorder, and bipolar disorder. Assessment for co-occurring mental health conditions is ongoing. The patient's history includes prior attempts at treatment for cocaine addiction, including outpatient counseling and a brief period of residential treatment. Current treatment plan includes referral to a substance abuse specialist for further evaluation and recommendation for an intensive outpatient program (IOP) addressing cocaine dependence. Patient education provided regarding the risks of continued cocaine abuse, including cardiovascular complications, neurological damage, and overdose. Focus of the treatment plan will include relapse prevention strategies, cognitive behavioral therapy (CBT), and motivational interviewing to promote sustained recovery from cocaine addiction. ICD-10 code F14.20 will be used for cocaine dependence, unspecified.
Effective interventions for cocaine use disorder (CUD) in primary care settings often involve a combination of approaches. Contingency management, using motivational incentives to reinforce abstinence, has demonstrated strong efficacy. Cognitive behavioral therapy (CBT) can equip patients with coping mechanisms to manage cravings and triggers. Motivational interviewing can help patients explore their ambivalence towards change and develop their own motivation for recovery. Pharmacotherapy options, while limited, can be considered in conjunction with behavioral interventions. Explore how integrating these evidence-based practices can improve patient outcomes in your primary care setting. Consider implementing routine screening for CUD to identify and address the issue early.
Differentiating between cocaine intoxication and other stimulant-induced psychosis requires careful assessment of the clinical presentation and history. While both can present with similar symptoms like agitation, paranoia, and hallucinations, specific features can point towards cocaine. Temporal correlation of symptom onset with cocaine use is crucial. Consider the presence of other cocaine-specific signs such as tachycardia, mydriasis, and elevated blood pressure. A thorough patient history, including substance use patterns and any pre-existing psychiatric conditions, is essential. Urine toxicology screening can confirm cocaine presence, but clinical judgment remains paramount. Learn more about the DSM-5 diagnostic criteria for stimulant intoxication and psychotic disorders to aid in accurate diagnosis and appropriate management.
Managing cocaine withdrawal symptoms requires a multi-pronged approach. Non-pharmacological interventions, such as providing a supportive and structured environment, are vital. Addressing co-occurring psychiatric disorders, like anxiety and depression, is crucial as they can exacerbate withdrawal and increase relapse risk. While no FDA-approved medications specifically target cocaine withdrawal, certain medications can help manage specific symptoms. For example, benzodiazepines might be considered for agitation and insomnia, while antidepressants can address co-occurring depression. Close monitoring and psychosocial support are essential during the acute withdrawal phase to mitigate relapse risk. Consider implementing a relapse prevention plan that incorporates CBT techniques and addresses individual patient triggers and vulnerabilities.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.